Targeted Therapy in HER2 Exon 20-Mutant Non-small Cell Lung Cancer With Leptomeningeal Disease: A Case-Based Approach to Treatment Decision-Making. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.